December 2008
Volume 49, Issue 12
Free
Immunology and Microbiology  |   December 2008
Evidence for Endotoxin as a Causative Factor for Leptospiral Uveitis in Humans
Author Affiliations
  • Chidambaranathan Gowri Priya
    From the Dr. G. Venkataswamy Eye Research Institute, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India; and the
  • Sivakumar R. Rathinam
    Uvea Clinic, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.
  • Veerappan Muthukkaruppan
    From the Dr. G. Venkataswamy Eye Research Institute, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India; and the
Investigative Ophthalmology & Visual Science December 2008, Vol.49, 5419-5424. doi:https://doi.org/10.1167/iovs.08-2174
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chidambaranathan Gowri Priya, Sivakumar R. Rathinam, Veerappan Muthukkaruppan; Evidence for Endotoxin as a Causative Factor for Leptospiral Uveitis in Humans. Invest. Ophthalmol. Vis. Sci. 2008;49(12):5419-5424. https://doi.org/10.1167/iovs.08-2174.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To understand the pathogenic mechanism of leptospiral uveitis by determining the profile of infiltrating cells, the levels of cytokines, and the causative factor in aqueous humor (AH).

methods. AH and blood samples were collected from 22 patients with leptospiral uveitis that was confirmed by microscopic agglutination test (MAT). Nine patients with Behçet’s uveitis, 10 with phacolytic uveitis, and 13 with age-related cataract were included as control subjects. A cytometric bead array was used to estimate human inflammatory and Th1/Th2 cytokines. The level of endotoxin in AH was estimated by limulus amebocyte lysate (LAL) test and by dot blot analysis using a leptospiral serovar lipopolysaccharide (LPS)–specific monoclonal antibody.

results. Except for one patient with leptospiral uveitis, AH from all other patients and control subjects was negative for Gram-negative bacterial endotoxin by LAL test. However, a significant level of serovar Copenhageni LPS was observed in AH of patients with leptospiral uveitis seropositive for the same serovar by MAT, in contrast to its absence in all control subjects. A selective infiltration of neutrophils as well as a significant increase in the levels of protein and cytokines IL-12p70, TNF, IL-6, IL-8, and IL-10 was observed in AH of patients with leptospiral uveitis. Phacolytic uveitis was associated with a high proportion of activated macrophages and increased levels of IL-6 and IL-8, whereas Behçet’s uveitis was associated with a predominant infiltration of neutrophils and increased levels of IFN-γ.

conclusions. The results demonstrate the presence of serovar-specific LPS in AH, and thus it is likely that endotoxin is a causative factor in leptospiral uveitis.

Leptospirosis is an acute febrile illness caused by the spirochete of the genus Leptospira. It is a potentially epidemic disease, commonly found in tropical countries with a humid climate. It can cause both life- and vision-threatening complications. Uveitis develops as a late complication of the systemic illness in 40% of patients and has been reported even 1 year after acute illness. 1 A major postmonsoon epidemic outbreak of leptospiral uveitis was reported from southern India in 1993. The patients had acute, anterior or pan, nongranulomatous uveitis with hypopyon. 2 The etiology of leptospiral uveitis was confirmed by demonstrating the presence of specific anti-leptospiral lipopolysaccharide (LPS) antibodies in the serum of patients with leptospiral uveitis. 3 4 However, the reason for the occurrence of acute ocular inflammation several weeks after recovery from acute systemic illness is not known. 
Several animal models are available that aid in understanding the pathogenic mechanism associated with the development of uveitis in humans. One such model is endotoxin-induced uveitis (EIU), in which systemic or intraocularly injected Salmonella typhi LPS migrates into the anterior chamber, possibly through the iris-ciliary body, resulting in a prominent infiltration of neutrophils and macrophages. The severity of uveitis is associated with elevated mRNA expression of TNF-α, IL-1β, IL-6, IFN-γ, MCP-1, and MCP-2 in the iris and ciliary body. 5 6 Further, intraocular injection of TNF, IL-1, IL-2, IL-6, or IFN-γ was shown to induce ocular inflammation in experimental animals. 7 8 However, in humans, the pathogenic mechanism in uveitis associated with systemic infection and the causative factors are still undefined. The purpose of the present study was to determine the profile of infiltrating cells, the levels of the different cytokines, and the lipopolysaccharide (LPS) in AH of patients with leptospiral uveitis. 
Materials and Methods
Recruitment of Cases
Patients attending the Uvea Clinic, Aravind Eye Hospital, with a clinical diagnosis of leptospiral uveitis 2 9 were recruited for the study. Demographic information on age, sex, place of residence, and socioeconomic status was collected on each patient. After a preliminary examination by a nonophthalmologist physician and a general ophthalmologist, all patients had a standard uveitis work-up. To identify the patients with a specific uveitis diagnosis, laboratory, and ancillary investigations were tailored for each patient, as determined by history and physical findings on presentation. Anatomic location of the inflammation was assigned based on International Uveitis Study Group criteria. 10 Established diagnostic criteria 11 were used to rule out other etiologic diagnoses, including HLA B27–related uveitis, Behçet’s syndrome, sarcoidosis, syphilis, tuberculosis, leprosy, acute retinal necrosis, VKH syndrome, and sympathetic ophthalmia. Cases were classified as idiopathic when a specific diagnosis was not known and were not included in the present study. 
Twenty-two patients with diagnosis of leptospiral uveitis based on a specific combination of clinical features 9 and a positive serology by MAT were included in the study. 4 Ten patients with phacolytic uveitis with hypopyon, nine with acute Behçet’s uveitis, three with Fuch’s heterochromic cyclitis, and two with sarcoidosis were selected as the nonleptospiral uveitis control group. Thirteen patients with uncomplicated, age-related cataract who showed no symptoms of systemic or ocular infection were also included as control subjects. The study was approved by the Institutional Review Board of Aravind Eye Hospital and adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all the patients before recruitment. 
Approximately 100 μL AH was collected from patients with leptospiral uveitis by anterior chamber paracentesis. Aqueous samples from patients with phacolytic uveitis, Behçet’s uveitis, or cataract were collected at the time of surgery. Blood (5 mL) was obtained from all patients for serologic analysis and smear preparation. All sera were stored at −80°C. 
Materials
Twenty leptospiral serovars and the monoclonal antibody F70 24-15 were obtained from Royal Tropical Institute, Amsterdam, The Netherlands. Cytometric bead array (CBA) kits for human inflammatory cytokines (IL-8, IL-1β, IL-6, IL-10, TNF and IL-12) and Th1/Th2 cytokines (IL-2, IL-4, IL-5, IL-10, TNF-α, and IFN-γ) were purchased from BD-Pharmingen (San Diego, CA); biotinylated goat anti-mouse Ig was obtained from DakoCytomation A/S (Glostrup, Denmark); streptavidin-HRP, 4-CN, BSA, Bradford reagent, and Folin Ciocalteau reagents were from Sigma-Aldrich (St. Louis, MO) and nitrocellulose (NC) from GE Healthcare (Braunschweig, Germany). Chromogenic limulus amebocyte lysate (LAL; QCL-1000) was purchased from Cambrex BioScience, Inc. (Walkersville, MD) and LAL reagent water from Salesworth India Pvt. Ltd. (Bangalore, India). 
Microscopic Agglutination Test (MAT)
All the serum samples were tested for the presence of anti-leptospiral antibodies by MAT. A panel of 20 serovars of Leptospira sp. was used as antigens and the end titer was defined as the highest dilution of serum having 50% agglutination. MAT was considered positive at 1:100 dilution of serum. 4 12  
Cytospin
Cells in AH were separated by centrifugation at 2000 rpm for 10 minutes at 4°C. The supernatant was transferred to a fresh tube and stored at −80°C for cytokine analysis. The cell pellet was resuspended in 200 μL of phosphate-buffered saline (PBS) and deposited onto glass slides by centrifuging at 400 rpm for 3 minutes (Shandon Cytospin 3; Thermo Fisher Scientific, Waltham, MA). After air drying, the blood smear and cytospin preparations were stained with Giemsa. The nature of infiltrating cells was then analyzed, and a minimum of 200 cells were counted for each sample. 
Cytokine Analysis
The levels of human inflammatory cytokines (IL-8, IL-1β, IL-6, IL-10, TNF, and IL-12) and Th1/Th2 cytokines (IL-2, IL-4, IL-5, IL-10, TNF-α, and IFN-γ) in AH and serum were determined by flow cytometry using CBA as per the manufacturer’s instructions (BD Biosciences). Briefly, the six capture bead populations with distinct fluorescence intensities that were coated with cytokine-specific capture antibodies were mixed together in equal volumes. To 50 μL of the mixed-bead population, 50 μL of the recombinant standards (20–5000 pg/mL) or AH or serum samples and 50 μL of PE-conjugated detection antibodies were added and incubated for 3 hours at 25°C in the dark, to form sandwich complexes. The beads were then washed with the wash buffer, and the sample data were acquired using flow cytometry (FACSCalibur with BD CBA Software; BD Biosciences). The standard curve and sample results were generated in graphic and tabular format. 
Protein Estimation
The protein concentration was determined in AH and serum by the method of Bradford 13 and Lowry, 14 respectively, using bovine serum albumin as the standard. 
Chromogenic LAL Test
The level of Gram-negative bacterial endotoxin was quantified using the LAL test as per the manufacturer’s instructions (Cambrex BioScience, Inc.). Briefly, 50 μL standard or AH from patients was mixed with LAL supplied in the kit and incubated at 37°C for 10 minutes. The substrate solution was then added and incubated at 37°C for an additional 6 minutes. The reaction was stopped with 25% vol/vol glacial acetic acid in LAL reagent water. The absorbance was then read at 405 nm with the ELISA reader. A standard curve was constructed by using the standard in the range 0.1 to 1.0 EU/mL, and the concentration of endotoxin in each sample was determined. Since we found inhibitory factors in AH, when spiked with the standard, the observed inhibition was overcome by heating the AH at 70°C for 10 minutes, at a dilution of 1:20. 
Leptospiral LPS Estimation
A Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni–specific monoclonal antibody (F70 24-15) was used to test for the presence of leptospiral LPS in AH. Antigen containing LPS from five leptospiral serogroups (Australis, Autumnalis, Icterohaemorrhagiae, Louisiana, and Patoc) were prepared according to a published protocol 4 and used to test for the specificity of the monoclonal antibody. The leptospiral antigen and AH were transferred to the NC membrane by a vacuum filtration method with a dot-blot apparatus (Bio-Rad, Hercules, CA). After blocking with 5% skimmed milk powder in PBS for 2 hours at room temperature, the blots were incubated with monoclonal antibody F70 C24 (1:1000), followed by biotinylated anti-mouse Ig (1:3000) and streptavidin HRP (1:1000) in 1% BSA in PBS-Tween 20 (PBS-T) for 1 hour each. The blots were washed with PBS-T after each incubation and developed with 4-CN. The results were read by measuring the intensity per square millimeter of the dot in the gel documentation system (Bio-Rad). Using different concentrations of the antigen containing LPS from L. interrogans serogroup Icterohaemorrhagiae (15–125 ng/dot), a standard curve was constructed with intensity per square millimeter in the x-axis and concentration in the y-axis. A linear curve was observed between the range 31 to 125 ng/dot, from which the unknown concentrations were calculated (Quantity One software; Bio-Rad). Since the volume of AH collected from patients with uveitis varied, it was not possible to load 100 μL in each uveitis sample. However, the concentration of LPS in all the samples was determined using the standard curve and extrapolated for 100 μL. 
Statistical Analysis
Analysis and graphic representation of the data was performed using commercial software (Stata, ver. 8.2 [Stata, College Station, TX] and Excel [Microsoft, Redmond, WA]). The data were tested using Mann-Whitney rank sum test with a significance level of 0.05. 
Results
All 22 patients with leptospiral uveitis were serologically confirmed by MAT for leptospiral infection. They were positive for the pathogenic L. interrogans serovars Copenhageni (n = 8), Icterohaemorrhagiae (n = 2), Autumnalis (n = 3), Australis (n = 2), Andamana (n = 1), Hardjo (n = 1), and Louisiana (n = 1) and to the saprophytic Leptospira biflexa serovar Patoc (n = 4). All the nonleptospiral uveitis and cataract patients recruited for the study were negative for leptospiral antibodies. 
Protein Exudation in AH
A significant (P < 0.01) increase in the level of protein was observed in AH of patients with leptospiral (median [minimum, maximum]: 5.3 mg/mL [0.95, 53]), phacolytic (10 mg/mL [3, 46.4]), or Behçet’s uveitis (13.94 mg/mL [2.0, 33.4]) compared with those with cataract (0.5 mg/mL [0.1, 0.8]). However, the serum protein levels were the same in all four groups (Fig. 1)
Selective Infiltration of Neutrophils
A significantly higher proportion (P < 0.001) of neutrophils was observed in the AH of patients with leptospiral or Behçet’s uveitis than in those phacolytic uveitis (Table 1) . The latter group was distinctly different from others on the basis of macrophages as predominant infiltrating cells. Comparison of the cellular profile in AH and corresponding blood samples indicated a selective infiltration of neutrophils in the AH of leptospiral and Behçet’s patients and macrophages in patients with phacolytic uveitis. No cells were observed in the AH of the cataract control subjects (Table 1)
Cytokines in AH and Serum
Fifty microliters of undiluted AH or serum samples were analyzed with CBA for human inflammatory and Th1/Th2 cytokines. A significantly higher concentration of IL-6, IL-8, IL-12p70, TNF, and IL-10 was observed in AH of patients with leptospiral uveitis than in control subjects with cataract (Fig. 2) . Further, leptospiral uveitis was significantly different from other types in IL-12p70, TNF, and IL-10. IL-6 levels were similar in all types of uveitis. 
As shown in Figure 3 , we did not observe increased levels of Th1/Th2 cytokines in patients with leptospiral uveitis. Of interest, the signatory Th1 cytokine IFN-γ, was significantly higher in Behçet’s uveitis than in control subjects with cataract. The levels of the inflammatory/Th1/Th2 cytokines in serum were below the detection limit in patients with leptospiral uveitis and control subjects. 
Level of Endotoxin in AH
LAL Estimation.
AH samples from five patients with leptospiral uveitis seropositive by MAT, three with Behçet’s uveitis and three with cataract were tested for the presence of endotoxin by LAL assay. Except for one AH (0.656 EU/mL) from a patient with leptospiral uveitis, all were negative for Gram-negative bacterial endotoxin. 
Dot Blot analysis.
Antigenic preparations containing LPS from different serogroups were used to test for the specificity of the monoclonal antibody for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni. A positive reaction was observed only with the antigen from serovar Copenhageni (Ictero-Cop) and not with other serogroups, indicating the specificity of the antibody (Fig. 4A) . Further, the positive reaction remained after the antigen was treated with proteinase K (Fig. 4B) ; but was totally lost after periodate treatment (Fig. 4C)confirming that LPS is the antigen detected by this monoclonal antibody. High levels of serovar-specific LPS was observed in AH of patients with leptospiral uveitis (Figs. 5 6)and interestingly, the sera of these patients were MAT positive for the same serovar Copenhageni. 
Discussion
Though there are animal models that aid in understanding the pathogenic mechanism associated with the development of uveitis, only sparse information is available on humans. Most of these reports are based on analysis of the cytokine levels in a heterogenous group of patients with uveitis, 15 16 17 18 19 only a few have analyzed the levels in the defined entity of uveitis. 20 21 22 The present study is the first of its kind in selecting a homogenous group of patients with uveitis of confirmed leptospiral etiology to identify the profile of cytokines in AH and to identify the associated causative factor. The etiology in all the recruited leptospiral uveitis cases was confirmed by MAT, the gold-standard test for leptospirosis, even in a geographic region like India where it is more common. 3 We have demonstrated that MAT positivity is due to IgM antibodies toward leptospiral LPS. 4  
Analysis of AH and corresponding blood samples from patients with leptospiral uveitis revealed: (1) protein exudation, the first sign in the breakdown of the blood–aqueous barrier, 23 (2) a selective infiltration of neutrophils into AH in contrast to that observed in autoimmune uveitis, mediated by T-cells 20 and (3) a higher level of the inflammatory cytokines IL-12p70, IFN-γ, TNF, IL-6, IL-8, and the regulatory cytokine IL-10 in AH compared with their serum samples, indicating local production. Thus, the specific profile of cytokines in AH of patients with leptospiral uveitis indicates that it is mediated by inflammatory cytokines, since the signatory cytokines of Th1/Th2 were not observed. Further, in vitro studies have shown that heat-killed leptospires were able to induce production of IL-12p40, TNF-α, and IFN-γ in whole blood from healthy volunteers. 24  
A crucial question on the pathogenesis of leptospiral uveitis is about the nature of the causative factor for inducing acute anterior uveitis, especially when there were no clinical symptoms of systemic leptospirosis at the time of presentation at the Uvea Clinic. The results on the cellular and cytokine analysis in patients with leptospiral uveitis correlate well with the findings in EIU, 25 but not with those in an experimental autoimmune uveoretinitis (EAU) animal model. 26 The positive correlation is based on the protein exudation, neutrophil infiltration, and the local production of the cytokines IL-12p70, IFN-γ, TNF, IL-6, IL-8, and IL-10 in AH, synthesized by the iris and ciliary body. 5 27 Therefore, it is possible on the basis of these findings that leptospiral LPS may be the initiating factor for the development of acute anterior uveitis, several weeks to months after systemic infection. There are reports to suggest that LPS from the circulation migrates into the anterior chamber, possibly through the iris-ciliary body at a concentration (1–10 ng) sufficient to induce inflammatory response. 28 29  
Leptospiral LPS is 10-fold less toxic compared with S. typhi LPS used in EIU models and other Gram-negative bacterial LPSs, and its reduced toxicity is due to the absence of β-hydroxy myristic acid, 30 but it has been demonstrated to activate macrophages in vitro. 31 The reduced toxicity may be the reason for the low sensitivity of the LAL assay, a functional assay of LPS toxicity, in patients with leptospiral uveitis. To overcome this, a method for estimating the level of leptospiral serovar-specific LPS was developed in this study using a monoclonal antibody specific for the L. interrogans serovar Copenhageni LPS O-antigen. 32 Of interest, higher levels of serovar-specific LPS was observed in patients with leptospiral uveitis, and these patients were also seropositive for the same serovar Copenhageni. These results indicate that the leptospiral LPS in the AH is from the original infecting organism. Further, the control subjects with Behçet’s uveitis and cataract were negative for Gram-negative endotoxin in their AH. Therefore, demonstration of a significant concentration of infecting serovar specific LPS in AH suggests that leptospiral uveitis is endotoxin mediated. However, the source and pathologic effect of leptospiral LPS in the AH must be elucidated. 
Behçet’s disease is a chronic inflammatory disorder characterized by recurrent attacks of different clinical manifestations, including oral ulcers, genital ulcers, uveitis, skin lesions, arthritis, venous thrombosis, arterial aneurysms, and lesions in the central nervous and gastrointestinal systems. 33 The etiology of Behçet’s disease is unknown but is considered to be chronic, autoimmune uveitis. In the present study, a predominant infiltration of neutrophils and a higher concentration of IFN-γ were observed in AH of Behçet’s uveitis, confirming the earlier reports of Shimada et al. 34 and Lacomba et al. 17  
Phacolytic uveitis, caused by the leakage of the lens proteins was included in the present study as the noninfectious uveitis control. Accordingly, leptospiral uveitis could be distinguished from phacolytic uveitis on the basis of the pattern of infiltrating cells 35 and cytokines. 
This study provided evidence that distinguishes leptospiral uveitis from phacolytic uveitis and Behçet’s uveitis (Table 2) . The specific combination of clinical features in leptospiral uveitis 9 along with laboratory confirmation of leptospiral etiology, the nature of infiltrating cells, and the profile of cytokines collectively indicate that leptospiral uveitis is a distinct entity, different from phacolytic, Behçet’s, and possibly other forms of uveitis. 
 
Figure 1.
 
Levels of protein in AH and serum of patients with leptospiral uveitis and control subjects. The lines within boxes indicate the median concentration of protein; hinges on top/bottom of box the upper/lower quartile, and horizontal lines above and below the boxes the most extreme values in the sample. *Significantly higher than in the cataract control (P < 0.001). LU, Leptospiral uveitis; PU, phacolytic uveitis; BU, Behçet’s uveitis; CC, cataract control.
Figure 1.
 
Levels of protein in AH and serum of patients with leptospiral uveitis and control subjects. The lines within boxes indicate the median concentration of protein; hinges on top/bottom of box the upper/lower quartile, and horizontal lines above and below the boxes the most extreme values in the sample. *Significantly higher than in the cataract control (P < 0.001). LU, Leptospiral uveitis; PU, phacolytic uveitis; BU, Behçet’s uveitis; CC, cataract control.
Table 1.
 
Profile of Infiltrating Cells in AH and Blood of Leptospiral Uveitis Patients and Control Subjects
Table 1.
 
Profile of Infiltrating Cells in AH and Blood of Leptospiral Uveitis Patients and Control Subjects
Cellular Profile Median (Minimum, Maximum)
Neutrophils (%) Lymphocytes (%) Monocytes (%) Macrophages (%) Eosinophils (%)
Aqucous humor
 Leptospiral uveitis (n = 10) 86 (56, 99)* , † 12 (1, 34), † 2 (0, 7) 0 0
 Phacolytic uveitis (n = 10) 2 (0, 18), † 8 (0, 13), † 2 (0, 5) 87 (70, 90) 0
 Behçet’s uveitis (n = 6) 85 (48, 91)* , † 9 (1, 15), † 2 (0, 2) 0 (0, 3) 0
 Cataract controls (n = 10) 0 0 0 0 0
Blood
 Leptospiral uveitis (n = 10) 64 (50, 76) 34 (21, 62) 1 (0, 3) 0 2 (0, 4)
 Phacolytic uveitis (n = 10) 62 (52, 81) 33 (16, 43) 3 (0, 6) 0 2 (0, 7)
 Behçet’s uveitis (n = 6) 73 (63, 89) 23 (5, 23) 3 (2, 5) 0 2 (1, 6)
 Cataract controls (n = 10) 69 (59, 76) 25 (22, 34) 4 (1, 5) 0 2 (1, 2)
Figure 2.
 
Inflammatory cytokines in AH of leptospiral uveitis and control. Fifty microliters of undiluted AH was analyzed by CBA for human inflammatory cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in phacolytic and Behçet’s uveitis (P < 0.05). Error bars, minimum and maximum values.
Figure 2.
 
Inflammatory cytokines in AH of leptospiral uveitis and control. Fifty microliters of undiluted AH was analyzed by CBA for human inflammatory cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in phacolytic and Behçet’s uveitis (P < 0.05). Error bars, minimum and maximum values.
Figure 3.
 
Th1/Th2 cytokines in AH of patients with uveitis and control subjects. Fifty microliter undiluted AH was analyzed by CBA for Th1/Th2 cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in the phacolytic, Behçet’s uveitis, and cataract control (P < 0.05). Error bars, minimum and maximum values.
Figure 3.
 
Th1/Th2 cytokines in AH of patients with uveitis and control subjects. Fifty microliter undiluted AH was analyzed by CBA for Th1/Th2 cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in the phacolytic, Behçet’s uveitis, and cataract control (P < 0.05). Error bars, minimum and maximum values.
Figure 4.
 
Confirmation that monoclonal antibody F70 24 is specific for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni LPS. Leptospiral LPS antigens (1.0 μg/dot) were spotted onto nitrocellulose membrane. Dot-blot analysis was performed without treatment (A), after proteinase K treatment (B), and after periodate treatment (C) of antigens using serovar Copenhageni-specific monoclonal antibody (1:1000) followed by biotinylated goat anti-mouse Ig (1:3000) and streptavidin-HRP (1:1000). Ictero-Cop, Serogroup Icterohaemorrhagiae serovar Copenhageni.
Figure 4.
 
Confirmation that monoclonal antibody F70 24 is specific for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni LPS. Leptospiral LPS antigens (1.0 μg/dot) were spotted onto nitrocellulose membrane. Dot-blot analysis was performed without treatment (A), after proteinase K treatment (B), and after periodate treatment (C) of antigens using serovar Copenhageni-specific monoclonal antibody (1:1000) followed by biotinylated goat anti-mouse Ig (1:3000) and streptavidin-HRP (1:1000). Ictero-Cop, Serogroup Icterohaemorrhagiae serovar Copenhageni.
Figure 5.
 
Estimation of leptospiral LPS in AH by dot-blot analysis. (A) Different concentrations of serovar Copenhageni LPS antigen were spotted to prepare the standard curve. (B) Indicated amount of AH of patients with leptospiral uveitis seropositive to serovar Copenhageni (LU-1 to LU-5) and (C) AH (100 μL) of cataract control samples (CC-1 to CC-5) were used as antigens, followed by Icterohaemorrhagiae LPS-specific monoclonal antibody (1:1000), biotinylated goat anti-mouse Ig (1:3000), and streptavidin-HRP (1:1000). Cop, serovar Copenhageni.
Figure 5.
 
Estimation of leptospiral LPS in AH by dot-blot analysis. (A) Different concentrations of serovar Copenhageni LPS antigen were spotted to prepare the standard curve. (B) Indicated amount of AH of patients with leptospiral uveitis seropositive to serovar Copenhageni (LU-1 to LU-5) and (C) AH (100 μL) of cataract control samples (CC-1 to CC-5) were used as antigens, followed by Icterohaemorrhagiae LPS-specific monoclonal antibody (1:1000), biotinylated goat anti-mouse Ig (1:3000), and streptavidin-HRP (1:1000). Cop, serovar Copenhageni.
Figure 6.
 
Amount of leptospiral LPS in AH of patients with leptospiral uveitis and control samples (seven samples/group). The level of leptospiral LPS in five AH samples included in Figure 5along with additional two samples from leptospiral uveitis were quantified and included in this graph. All seven were from patients who were MAT seropositive for the L. interrrogans serogroup Icterohaemorrhagiae serovar Copenhageni. *Significantly higher than nonleptospiral uveitis and cataract control subjects (P < 0.05).
Figure 6.
 
Amount of leptospiral LPS in AH of patients with leptospiral uveitis and control samples (seven samples/group). The level of leptospiral LPS in five AH samples included in Figure 5along with additional two samples from leptospiral uveitis were quantified and included in this graph. All seven were from patients who were MAT seropositive for the L. interrrogans serogroup Icterohaemorrhagiae serovar Copenhageni. *Significantly higher than nonleptospiral uveitis and cataract control subjects (P < 0.05).
Table 2.
 
Comparison of Clinical and Laboratory Findings in Leptospiral Uveitis Patients with Control Subjects
Table 2.
 
Comparison of Clinical and Laboratory Findings in Leptospiral Uveitis Patients with Control Subjects
Leptospiral Uveitis (n = 22) Phacolytic Uveitis (n = 10) Behçet’s Uveitis (n = 9) Cataract Controls (n = 13)
Clinical presentation Acute Acute Chronic
Clinical presentation Unilateral/bilateral Unilateral Unilateral/Bilateral
Clinical presentation Anterior/pan uveitis Anterior uveitis Pan uveitis
Clinical presentation Infectious Noninfectious Autoimmune
IgM antibodies to leptospiral LPS in serum by MAT +
Protein exudation in AH ++ ++ ++
Cellular infiltration in AH
 Neutrophils +++ +++
 Macrophages +++
 Lymphocytes + + +
 Monocytes + + +
Cytokines in AH
 IL-6 +++ +++ ++ ±
 IL-8 +++ ++ ++ ±
 IL-12p70 ++ +
 TNF ++ + +
 IL-10 ++ +
 IFN-γ + +++
Leptospiral LPS in AH ++
The authors thank Rudy A. Hartskeerl (Royal Tropical Institute) for providing the monoclonal antibody; Mahadevan Kannan and Somasundaram Karthick Prakash (Lions Aravind Institute of Community Ophthalmology, Aravind Eye Care System) for help with the statistical analysis; and Meenakshisundaram Nellaiappan Anbu Mari and Kalangiam Alageswari (Aravind Medical Research Foundation) for assistance in cellular and cytokine analysis. 
SturmanRM, LavalJ, WeilVJ. Leptospiral uveitis. Am J Ophthalmol. 1949;32:1564–1566. [CrossRef] [PubMed]
RathinamSR, RathnamS, SelvarajS, DeanD, NozikRA, NamperumalsamyP. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol. 1997;124:71–79. [CrossRef] [PubMed]
RathinamS, RatnamS, SureshbabuL, NatarajaseenivasanK. Leptospiral antibodies in patients with recurrent ophthalmic involvement. Indian J Med Res. 1996;103:66–68. [PubMed]
PriyaCG, BhavaniK, RathinamSR, MuthukkaruppanVR. Identification and evaluation of LPS antigen for serodiagnosis of uveitis associated with leptospirosis. J Med Microbiol. 2003;52:667–673. [CrossRef] [PubMed]
PlankSR, HuangXN, RobertsonJE, RosenbaumJT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci. 1994;35(3)924–930. [PubMed]
Guex-CrosierY, WittwerAJ, RobergeFG. Intraocular production of a cytokine (CINC) responsible for neutrophil infiltration in endotoxin induced uveitis. Br J Ophthalmol. 1996;80:649–653. [CrossRef] [PubMed]
SamplesJR, BoneyRS, RosenbaumJT. Ocular inflammatory effects of intravitreally injected interleukin-2. Curr Eye Res. 1993;12:649–654. [CrossRef] [PubMed]
LeeSF, PeposeJS. Cellular immune response to Ia induction by intraocular gamma-interferon. Ophthalmic Res. 1990;22:310–317. [CrossRef] [PubMed]
RathinamSR. Studies on Clinical Presentation, Diagnosis and Management of Infectious Uveitis with Reference to Leptospirosis. PhD thesis.. 2006;MGR University Chennai, India.
Bloch-MichelE, NussenblattRB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–235. [CrossRef] [PubMed]
NussenblattRB, WhitcupSM, PalestineAG. Examination of the patient with uveitis.NussenblattRB WhitcupSM PalestineAG eds. Uveitis: Fundamentals and Clinical Practice. 1996; 2nd ed. 58–68.Mosby St. Louis.
TerpstraWJ, LighartGS, SchooneGJ. ELISA for the detection of specific IgM and IgG in human leptospirosis. J Gen Microbiol. 1985;131:377–385. [PubMed]
BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. [CrossRef] [PubMed]
LowryOH, RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed]
VermaMJ, LloydA, RagerH, et al. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16:1202–1208. [CrossRef] [PubMed]
el-ShabrawiY, Livir-RallatosC, ChristenW, BaltatzisS, FosterCS. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmol. 1998;105:1659–1663. [CrossRef]
LacombaMS, MartinCM, ChamondRR, GaleraJM, OmarM, EstevezEC. Aqueous humor and serum interferon-γ, interleukin (IL) 2, IL-4 and IL-10 in patients with uveitis. Arch Ophthalmol. 2000;118:768–772. [CrossRef] [PubMed]
CurnowSJ, FalcianiF, DurraniOM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci. 2005;46(11)4251–4259. [CrossRef] [PubMed]
OoiKGJ, GalatowiczG, TowlerHMA, LightmanSL, CalderVL. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10 and IFNγ profiles in uveitis. Invest Ophthalmol Vis Sci. 2006;47:272–277. [CrossRef] [PubMed]
NoroseK, YanoA, WangXC, et al. Dominance of activated T cells and interleukin-6 in AH in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 1994;35:33–39. [PubMed]
OngkosuwitoJV, FeronEJ, van DoornikCE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659–2665. [PubMed]
TakaseH, FutagamiY, YoshidaT, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006;47(4)1557–1561. [CrossRef] [PubMed]
KrauseU, RaunioV. The proteins of the pathologic human aqueous humor: an in vivo investigation. Ophthalmologica. 1970;160:280–287. [CrossRef] [PubMed]
de FostM, HartskeerlRA, GroenendijkMR, van der PollT. Interleukin 12 in part regulates gamma interferon release in human whole blood stimulated with Leptospira interrogans. Clin Diagn Lab Immunol. 2003;10(2)332–335. [PubMed]
RosenbaumJT, McDevittHO, GussRB, EgbertPR. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980;286:611–613. [CrossRef] [PubMed]
WackerWB. Proctor Lecture. Experimental allergic uveitis: investigations of retinal autoimmunity and the immunopathologic responses evoked. Invest Ophthalmol Vis Sci. 1991;32:3119–3128. [PubMed]
de VosAF, van HarenMA, VerhagenC, HoekzemaR, KijlstraA. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35:1100–1106. [PubMed]
HowesEL, Jr, HoffmanMA, UlevitchRJ, MathisonJC, MorrisonDC. Ocular localization of circulating bacterial lipopolysaccharide. Exp Eye Res. 1984;38(4)379–389. [CrossRef] [PubMed]
OhtaK, WiggertB, TaylorAW, StreileinJW. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci. 1999;40:2010–2018. [PubMed]
FaineS, AdlerB, BolinC, PerolatP. Leptospira and Leptospirosis. 1999; 2nd ed.MediSci Melbourne, Australia.
IsogaiE, IsogaiH, FujiiN, OgumaK. Macrophage activation by leptospiral lipopolysaccharide. Zent Bakt. 1990;273:200–208. [CrossRef]
NallyJE, ChowE, FishbeinMC, BlancoDR, LovettMA. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun. 2005;73(6)3251–3260. [CrossRef] [PubMed]
SakaneT, TakenoM, SuzukiN, InabaG. Bechet’s disease. N Engl J Med. 1999;341(17)1284–1291. [CrossRef] [PubMed]
ShimadaK, YaoitaH, ShikanoS. Chemotactic activity for polymorphonuclear leucocytes of the aqueous humor in patients with Behcet’s disease. Nippon Ganka Gakkai Zasshi. 1971;75(10)2100–2105. [PubMed]
FlocksM, LittwinCS, ZimmermanLE. Phacolytic glaucoma: a clinicopathologic study of one hundred thirty-eight cases of glaucoma associated with hypermature cataract. AMA Arch Ophthalmol. 1955;54:37–45. [CrossRef] [PubMed]
Figure 1.
 
Levels of protein in AH and serum of patients with leptospiral uveitis and control subjects. The lines within boxes indicate the median concentration of protein; hinges on top/bottom of box the upper/lower quartile, and horizontal lines above and below the boxes the most extreme values in the sample. *Significantly higher than in the cataract control (P < 0.001). LU, Leptospiral uveitis; PU, phacolytic uveitis; BU, Behçet’s uveitis; CC, cataract control.
Figure 1.
 
Levels of protein in AH and serum of patients with leptospiral uveitis and control subjects. The lines within boxes indicate the median concentration of protein; hinges on top/bottom of box the upper/lower quartile, and horizontal lines above and below the boxes the most extreme values in the sample. *Significantly higher than in the cataract control (P < 0.001). LU, Leptospiral uveitis; PU, phacolytic uveitis; BU, Behçet’s uveitis; CC, cataract control.
Figure 2.
 
Inflammatory cytokines in AH of leptospiral uveitis and control. Fifty microliters of undiluted AH was analyzed by CBA for human inflammatory cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in phacolytic and Behçet’s uveitis (P < 0.05). Error bars, minimum and maximum values.
Figure 2.
 
Inflammatory cytokines in AH of leptospiral uveitis and control. Fifty microliters of undiluted AH was analyzed by CBA for human inflammatory cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in phacolytic and Behçet’s uveitis (P < 0.05). Error bars, minimum and maximum values.
Figure 3.
 
Th1/Th2 cytokines in AH of patients with uveitis and control subjects. Fifty microliter undiluted AH was analyzed by CBA for Th1/Th2 cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in the phacolytic, Behçet’s uveitis, and cataract control (P < 0.05). Error bars, minimum and maximum values.
Figure 3.
 
Th1/Th2 cytokines in AH of patients with uveitis and control subjects. Fifty microliter undiluted AH was analyzed by CBA for Th1/Th2 cytokines. *Significantly higher than in the cataract control (P < 0.05); †Significantly higher than in the phacolytic, Behçet’s uveitis, and cataract control (P < 0.05). Error bars, minimum and maximum values.
Figure 4.
 
Confirmation that monoclonal antibody F70 24 is specific for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni LPS. Leptospiral LPS antigens (1.0 μg/dot) were spotted onto nitrocellulose membrane. Dot-blot analysis was performed without treatment (A), after proteinase K treatment (B), and after periodate treatment (C) of antigens using serovar Copenhageni-specific monoclonal antibody (1:1000) followed by biotinylated goat anti-mouse Ig (1:3000) and streptavidin-HRP (1:1000). Ictero-Cop, Serogroup Icterohaemorrhagiae serovar Copenhageni.
Figure 4.
 
Confirmation that monoclonal antibody F70 24 is specific for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni LPS. Leptospiral LPS antigens (1.0 μg/dot) were spotted onto nitrocellulose membrane. Dot-blot analysis was performed without treatment (A), after proteinase K treatment (B), and after periodate treatment (C) of antigens using serovar Copenhageni-specific monoclonal antibody (1:1000) followed by biotinylated goat anti-mouse Ig (1:3000) and streptavidin-HRP (1:1000). Ictero-Cop, Serogroup Icterohaemorrhagiae serovar Copenhageni.
Figure 5.
 
Estimation of leptospiral LPS in AH by dot-blot analysis. (A) Different concentrations of serovar Copenhageni LPS antigen were spotted to prepare the standard curve. (B) Indicated amount of AH of patients with leptospiral uveitis seropositive to serovar Copenhageni (LU-1 to LU-5) and (C) AH (100 μL) of cataract control samples (CC-1 to CC-5) were used as antigens, followed by Icterohaemorrhagiae LPS-specific monoclonal antibody (1:1000), biotinylated goat anti-mouse Ig (1:3000), and streptavidin-HRP (1:1000). Cop, serovar Copenhageni.
Figure 5.
 
Estimation of leptospiral LPS in AH by dot-blot analysis. (A) Different concentrations of serovar Copenhageni LPS antigen were spotted to prepare the standard curve. (B) Indicated amount of AH of patients with leptospiral uveitis seropositive to serovar Copenhageni (LU-1 to LU-5) and (C) AH (100 μL) of cataract control samples (CC-1 to CC-5) were used as antigens, followed by Icterohaemorrhagiae LPS-specific monoclonal antibody (1:1000), biotinylated goat anti-mouse Ig (1:3000), and streptavidin-HRP (1:1000). Cop, serovar Copenhageni.
Figure 6.
 
Amount of leptospiral LPS in AH of patients with leptospiral uveitis and control samples (seven samples/group). The level of leptospiral LPS in five AH samples included in Figure 5along with additional two samples from leptospiral uveitis were quantified and included in this graph. All seven were from patients who were MAT seropositive for the L. interrrogans serogroup Icterohaemorrhagiae serovar Copenhageni. *Significantly higher than nonleptospiral uveitis and cataract control subjects (P < 0.05).
Figure 6.
 
Amount of leptospiral LPS in AH of patients with leptospiral uveitis and control samples (seven samples/group). The level of leptospiral LPS in five AH samples included in Figure 5along with additional two samples from leptospiral uveitis were quantified and included in this graph. All seven were from patients who were MAT seropositive for the L. interrrogans serogroup Icterohaemorrhagiae serovar Copenhageni. *Significantly higher than nonleptospiral uveitis and cataract control subjects (P < 0.05).
Table 1.
 
Profile of Infiltrating Cells in AH and Blood of Leptospiral Uveitis Patients and Control Subjects
Table 1.
 
Profile of Infiltrating Cells in AH and Blood of Leptospiral Uveitis Patients and Control Subjects
Cellular Profile Median (Minimum, Maximum)
Neutrophils (%) Lymphocytes (%) Monocytes (%) Macrophages (%) Eosinophils (%)
Aqucous humor
 Leptospiral uveitis (n = 10) 86 (56, 99)* , † 12 (1, 34), † 2 (0, 7) 0 0
 Phacolytic uveitis (n = 10) 2 (0, 18), † 8 (0, 13), † 2 (0, 5) 87 (70, 90) 0
 Behçet’s uveitis (n = 6) 85 (48, 91)* , † 9 (1, 15), † 2 (0, 2) 0 (0, 3) 0
 Cataract controls (n = 10) 0 0 0 0 0
Blood
 Leptospiral uveitis (n = 10) 64 (50, 76) 34 (21, 62) 1 (0, 3) 0 2 (0, 4)
 Phacolytic uveitis (n = 10) 62 (52, 81) 33 (16, 43) 3 (0, 6) 0 2 (0, 7)
 Behçet’s uveitis (n = 6) 73 (63, 89) 23 (5, 23) 3 (2, 5) 0 2 (1, 6)
 Cataract controls (n = 10) 69 (59, 76) 25 (22, 34) 4 (1, 5) 0 2 (1, 2)
Table 2.
 
Comparison of Clinical and Laboratory Findings in Leptospiral Uveitis Patients with Control Subjects
Table 2.
 
Comparison of Clinical and Laboratory Findings in Leptospiral Uveitis Patients with Control Subjects
Leptospiral Uveitis (n = 22) Phacolytic Uveitis (n = 10) Behçet’s Uveitis (n = 9) Cataract Controls (n = 13)
Clinical presentation Acute Acute Chronic
Clinical presentation Unilateral/bilateral Unilateral Unilateral/Bilateral
Clinical presentation Anterior/pan uveitis Anterior uveitis Pan uveitis
Clinical presentation Infectious Noninfectious Autoimmune
IgM antibodies to leptospiral LPS in serum by MAT +
Protein exudation in AH ++ ++ ++
Cellular infiltration in AH
 Neutrophils +++ +++
 Macrophages +++
 Lymphocytes + + +
 Monocytes + + +
Cytokines in AH
 IL-6 +++ +++ ++ ±
 IL-8 +++ ++ ++ ±
 IL-12p70 ++ +
 TNF ++ + +
 IL-10 ++ +
 IFN-γ + +++
Leptospiral LPS in AH ++
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×